These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
762 related items for PubMed ID: 30109543
1. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Mirili C, Guney IB, Paydas S, Seydaoglu G, Kapukaya TK, Ogul A, Gokcay S, Buyuksimsek M, Yetisir AE, Karaalioglu B, Tohumcuoglu M. Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543 [Abstract] [Full Text] [Related]
3. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer]. Ding CY, Guo Z, Li YY, Li TR. Zhonghua Zhong Liu Za Zhi; 2017 Nov 23; 39(11):828-834. PubMed ID: 29151289 [Abstract] [Full Text] [Related]
4. Prognostic significance of metabolic parameters measured by 18F-FDG PET/CT in limited-stage small-cell lung carcinoma. Chang H, Lee SJ, Lim J, Lee JS, Kim YJ, Lee WW. J Cancer Res Clin Oncol; 2019 May 23; 145(5):1361-1367. PubMed ID: 30900157 [Abstract] [Full Text] [Related]
5. Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis. Nie K, Zhang YX, Nie W, Zhu L, Chen YN, Xiao YX, Liu SY, Yu H. J Med Imaging Radiat Oncol; 2019 Feb 23; 63(1):84-93. PubMed ID: 30230710 [Abstract] [Full Text] [Related]
6. The prognostic role of PET/CT in small-cell lung cancer. Budak E, Yanarateş A, Akgün A. Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020 Feb 23; 39(1):9-13. PubMed ID: 31865009 [Abstract] [Full Text] [Related]
7. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH, Cho A, Yun M, Choi YD, Rha SY, Kang WJ. Clin Nucl Med; 2017 May 23; 42(5):e235-e241. PubMed ID: 28288043 [Abstract] [Full Text] [Related]
8. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y. Acad Radiol; 2013 Jan 23; 20(1):32-40. PubMed ID: 22999369 [Abstract] [Full Text] [Related]
9. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer. Ong LT, Dunphy M, Foster A, Woo KM, Zhang Z, Perez CA, Pietanza CM, Rosenzweig KE, Gelblum DY, Rimner A, Wu AJ. Clin Lung Cancer; 2016 May 23; 17(3):184-8. PubMed ID: 26320828 [Abstract] [Full Text] [Related]
10. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on 18F-FDG PET/CT in Patients With Limited-stage Small-cell Lung Cancer With Lymph Node Involvement. Jin F, Qu B, Fu Z, Zhang Y, Han A, Kong L, Yu J. Clin Lung Cancer; 2018 Jan 23; 19(1):e101-e108. PubMed ID: 28690012 [Abstract] [Full Text] [Related]
11. Prognostic impact of the 18F-fluorodeoxyglucose positron-emission tomography/computed tomography metabolic parameters and correlation with hematological inflammatory markers in lung cancer. Goksel S, Cengiz A, Ozturk H, Yurekli Y. J Cancer Res Ther; 2021 Jan 23; 17(4):925-930. PubMed ID: 34528543 [Abstract] [Full Text] [Related]
12. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer. Zhu D, Ma T, Niu Z, Zheng J, Han A, Zhao S, Yu J. Lung Cancer; 2011 Sep 23; 73(3):332-7. PubMed ID: 21292341 [Abstract] [Full Text] [Related]
13. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy. Sharma A, Mohan A, Bhalla AS, Sharma MC, Vishnubhatla S, Das CJ, Pandey AK, Sekhar Bal C, Patel CD, Sharma P, Agarwal KK, Kumar R. Clin Nucl Med; 2018 Jan 23; 43(1):e8-e17. PubMed ID: 29112011 [Abstract] [Full Text] [Related]
16. Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer. Oh JR, Seo JH, Hong CM, Jeong SY, Lee SW, Lee J, Min JJ, Song HC, Bom HS, Kim YC, Ahn BC. Lung Cancer; 2013 Aug 23; 81(2):218-25. PubMed ID: 23731740 [Abstract] [Full Text] [Related]
17. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Chen HH, Chiu NT, Su WC, Guo HR, Lee BF. Radiology; 2012 Aug 23; 264(2):559-66. PubMed ID: 22692034 [Abstract] [Full Text] [Related]
18. Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer. Oh JR, Seo JH, Chong A, Min JJ, Song HC, Kim YC, Bom HS. Eur J Nucl Med Mol Imaging; 2012 Jun 23; 39(6):925-35. PubMed ID: 22270509 [Abstract] [Full Text] [Related]
19. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer. Hu WD, Wang HC, Wang YB, Cui LL, Chen XH. Q J Nucl Med Mol Imaging; 2021 Jun 23; 65(2):172-177. PubMed ID: 30916535 [Abstract] [Full Text] [Related]
20. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma. Satoh K, Patel D, Dieckmann W, Nilubol N, Kebebew E. Ann Surg Oncol; 2015 Dec 23; 22 Suppl 3():S714-20. PubMed ID: 26282908 [Abstract] [Full Text] [Related] Page: [Next] [New Search]